Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 27 2021

Yellow Fever

  • Snapshot
    • A 32-year-old woman presents to a local clinic in Nigeria. She had been working in the rainforest as part of a conservation movement and had been bitten multiple times over the past few days by mosquitos and other flying insects. Three days ago, she developed a flu-like viral illness and recently began having minor nosebleeds. She also noted that her skin looked more yellow than normal. On exam, she is jaundiced with scleral icterus. She is also noted to have hepatomegaly and gingival bleeding. Laboratory testing reveals a transaminitis and hyperbilirubinemia. She is told that she needs to be admitted for close monitoring.
  • Introduction
    • Classification
      • yellow fever virus
        • a positive-stranded, linear RNA virus
        • a flavivirus and arbovirus with icosahedral capsid
        • transmitted by Aedes mosquito
        • reservoir is human or monkey
    • Pathogenesis
      • the virus spreads via blood
      • it infects the liver
        • liver cells die via apoptosis
        • coagulopathy occurs due to loss of hepatic synthesis of clotting factors
  • Epidemiology
    • Incidence
      • endemic in South America and Africa
    • Risk factors
      • exposure to endemic areas
      • mosquito bites
  • Presentation
    • Symptoms
      • most patients are asymptomatic
      • if symptomatic
        • flu-like prodrome
        • headache
        • myalgias
        • nausea
        • black vomitus
    • Physical exam
      • high fever
      • jaundice
      • scleral icterus
      • hepatomegaly
      • minor hemorrhage
        • epistaxis
        • mucosal bleeding
        • melena
  • Studies
    • Labs
      • diagnostic
        • reverse transcriptase-polymerase chain reaction
        • serology with enzyme-linked immunosorbent assay
      • transaminitis (AST > ALT)
      • elevated prothrombin and partial thromboplastin times
      • hyperbilirubinemia
    • Guaiac stool testing
      • occult blood
    • Liver biopsy
      • Councilman bodies
        • eosinophilic apoptotic globules
      • typically found on autopsy
    • Making the diagnosis
      • most cases are clinically diagnosed, especially in those who have recently traveled to an endemic area
  • Differential
    • Dengue fever
      • distinguishing factor
        • may also be hemorrhagic but does not affect the liver
        • will not present with jaundice, scleral icterus, and hepatomegaly
    • Chikungunya
      • distinguishing factor
        • typically does not present with hemorrhage
  • Treatment
    • Conservative
      • supportive care
        • indication
          • all patients
        • modalities
          • rehydration
          • close monitoring
          • pain control
  • Associated conditions
    • hemorrhagic fever
  • Prevention
    • Live-attenuated virus vaccine
      • given at age 9-12 months in endemic areas
      • given 10 days prior to travel to endemic areas
  • Complications
    • Shock
    • Death
    • Prolonged weakness and fatigue
  • Prognosis
    • Most patients recover without complications
    • However, in severe cases, mortality rate is up to 60%
1 of 0
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options